DGAT2 and fatty liver disease: DGAT catalyses the committed step in triacylglycerol synthesis with DGAT2 being the dominant DGAT enzyme controlling triacylglycerol homeostasis in vivo[23], and PNPLA3 has been implicated in the development of hepatic steatosis [24].